Streetbeat News

Products Services

AUGX

Augmedix (NASDAQ:AUGX), specializing in ambient AI medical documentation and data solutions, has announced a partnership with SADA, a leading cloud business and technology consultancy. This collaboration aims to leverage their combined technology expertise to expand their reach and provide enhanced product and service value to health systems nationwide, focusing on high-quality ambient documentation and structured data products.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 11:12 am

GRYP

Gryphon Digital Mining, Inc. (NASDAQ:GRYP) announced its March 2024 operational update, highlighting the production of approximately 45 bitcoin, valued at around $3.1 million. The company, which operates on 100% renewable energy, achieved a new record in average self-mining hashing power of 912 PH/s and a bitcoin efficiency of 49 BTC/EH. Gryphon also initiated a machine upgrade program with the purchase of Bitmain S21 200 TH/s machines and reported having 59 bitcoin in its treasury as of March 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 11:09 am

CVAC

GSK

CureVac N.V. announced interim Phase 2 data from its seasonal influenza vaccine development program, conducted in collaboration with GSK. The vaccine candidate, designed for broad antigen coverage, encodes antigens for all four WHO-recommended flu strains.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 11:07 am

GILT

Gilat Satellite Networks has announced receiving a follow-on order worth over $3M for a public WiFi solution in Latin America, aimed at extending the number of sites in a program focused on social inclusion and bridging the digital divide.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 11:06 am

AAPL

XIACF

Apple Inc. scales back its electric vehicle (EV) plans, while Chinese smartphone companies, notably Xiaomi Corp., are aggressively expanding into the EV market. Xiaomi's entry with the SU7 sedan has garnered significant investor interest, demonstrated by a 9% stock increase and nearly 90,000 orders within 24 hours. Huawei is also entering the EV space through partnerships. Apple's pivot to home robotics marks a strategic shift away from EVs, opening opportunities for companies like Xiaomi and Huawei.

Portfolio Pulse from Benzinga Neuro

April 04, 2024 | 11:00 am

ANGO

AngioDynamics has received FDA 510(k) clearance for its AlphaVac F1885 System for the treatment of pulmonary embolism (PE), expanding its applicability in the non-surgical removal of thrombi or emboli from the venous vasculature. This clearance broadens treatment options for PE patients, aiming to reduce thrombus burden and improve right ventricular function.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 10:46 am

NVDA

Jim Cramer emphasized the underappreciated potential of AI in businesses and the stock market, specifically mentioning Nvidia's role as a pioneer. He criticized the shift of investor focus towards refinery and dollar store stocks, highlighting that AI's transformative impact is yet to be fully realized. Cramer believes AI is still in its early stages, likening it to 'batting practice' and suggesting it could replace physically demanding jobs and aid underfunded businesses. Despite debates on an AI bubble, with contrasting views from industry figures, Nvidia's stock saw a slight decline.

Portfolio Pulse from Benzinga Neuro

April 04, 2024 | 10:45 am

AAPL

Apple Inc. is gearing up for the release of its iPhone 16 series in September, featuring larger screens, a new design, improved performance, and potential new technologies such as OLED displays with MLA technology, a super telephoto periscope camera, and the A17 or A18 Bionic chips. The series may also introduce a polished titanium finish and new color options.

Portfolio Pulse from Ananya Gairola

April 04, 2024 | 10:45 am

KIND

Nextdoor has announced the launch of its Ads API program, aimed at enhancing advertising capabilities on its platform. This move is expected to attract more advertisers by offering improved ad targeting and performance tracking features.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 10:35 am

HAE

Haemonetics has received 510(k) clearance from the FDA for its TEG 6s Hemostasis Analyzer System Global Hemostasis-HN Assay Cartridge. This new cartridge enhances the TEG 6s system's capabilities, allowing it to serve fully heparinized patients undergoing adult cardiovascular surgeries/procedures and liver transplantation in both laboratory and point-of-care settings.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 10:32 am